Patient beliefs that chemotherapy may be curative and care received at the end of life among patients with metastatic lung and colorectal cancer

Cancer

Volumn 121, Issue 11, 2015, Pages 1891-1897

  Mack, Jennifer W ^a   Walling, Anne ^b,c   Dy, Sydney ^d   Antonio, Anna Liza M ^b,c,e   Adams, John ^b,c   Keating, Nancy L ^f,g   Tisnado, Diana ^h  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

chemotherapy; communication; end of life; informed consent; palliative

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; AWARENESS; CANCER CHEMOTHERAPY; CANCER STAGING; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COLORECTAL CANCER; FEMALE; FOLLOW UP; HEALTH EDUCATION; HOSPICE CARE; HUMAN; INFORMED CONSENT; LIFE SUSTAINING TREATMENT; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT DECISION MAKING; PATIENT PREFERENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; COLORECTAL NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; PALLIATIVE THERAPY; PATHOLOGY; PROCEDURES; PSYCHOLOGY; TERMINAL CARE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; TERMINAL CARE; YOUNG ADULT;

EID: 84929656524     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29250     Document Type: Article

References (30)

1. Institute of Medicine. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. Washington, DC: National Academies Press; 2013.
2. Weeks JC, Catalano PJ, Cronin A, et al., Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med. 2012; 367: 1616-1625.
3. Weeks JC, Cook EF, O'Day SJ, et al., Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA. 1998; 279: 1709-1714.
4. Liu PH, Landrum MB, Weeks JC, et al., Physicians' propensity to discuss prognosis is associated with patients' awareness of prognosis for metastatic cancers. J Palliat Med. 2014; 17: 673-682.
5. Wright AA, Zhang B, Ray A, et al., Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008; 300: 1665-1673.
6. Mack JW, Cronin A, Taback N, et al., End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med. 2012; 156: 204-210.
7. Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC,. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004; 22: 315-321.
8. Teno JM, Gozalo PL, Bynum JP, et al., Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009. JAMA. 2013; 309: 470-477.
9. Ayanian JZ, Chrischilles EA, Fletcher RH, et al., Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance consortium. J Clin Oncol. 2004; 22: 2992-2996.
10. Catalano PJ, Ayanian JZ, Weeks JC, et al,; Cancer Care Outcomes Research Surveillance Consortium. Representativeness of participants in the Cancer Care Outcomes Research and Surveillance consortium relative to the Surveillance, Epidemiology, and End Results program. Med Care. 2013; 51: e9-e15.
11. Chen JY, Tao ML, Tisnado D, et al., Impact of physician-patient discussions on patient satisfaction. Med Care. 2008; 46: 1157-1162.
12. Hays RD, Shaul JA, Williams VS, et al., Psychometric properties of the CAHPS 1.0 survey measures. Consumer Assessment of Health Plans Study. Med Care. 1999; 37 (suppl): MS22-MS31.
13. Ayanian JZ, Zaslavsky AM, Arora NK, et al., Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance consortium. J Clin Oncol. 2010; 28: 4154-4161.
14. Shaw JW, Johnson JA, Coons SJ,. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005; 43: 203-220.
15. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW,. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996; 34: 73-84.
16. Klabunde CN, Reeve BB, Harlan LC, Davis WW, Potosky AL,. Do patients consistently report comorbid conditions over time?: results from the Prostate Cancer Outcomes Study. Med Care. 2005; 43: 391-400.
17. He Y,. Missing data analysis using multiple imputation: getting to the heart of the matter. Circ Cardiovasc Qual Outcomes. 2010; 3: 98-105.
18. He Y, Zaslavsky AM, Landrum MB, Harrington DP, Catalano P,. Multiple imputation in a large-scale complex survey: a practical guide. Stat Methods Med Res. 2009; 19: 653-670.
19. Mack JW, Cronin A, Keating NL, et al., Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol. 2012; 30: 4387-4395.
20. National Consensus Project for Quality Palliative Care. Clinical practice guidelines for quality palliative care. http://www.nationalconsensusproject.org. Accessed December 2014.
21. National Comprehensive Cancer Network. Practice guidelines in oncology: palliative care. http://www.nccn.org/professionals/physicians-gls/PDP/palliative.pdf. Accessed December 2014.
22. Wright AA, Keating NL, Balboni TA, Matulonis UA, Block SD, Prigerson HG,. Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health. J Clin Oncol. 2010; 28: 4457-4464.
23. Teno JM, Clarridge BR, Casey V, et al., Family perspectives on end-of-life care at the last place of care. JAMA. 2004; 291: 88-93.
24. Wright AA, Zhang B, Keating NL, Weeks JC, Prigerson HG,. Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study. BMJ. 2014; 348: g1219.
25. Greer JA, Pirl WF, Jackson VA, et al., Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol. 2012; 30: 394-400.
26. Loggers ET, Maciejewski PK, Paulk E, et al., Racial differences in predictors of intensive end-of-life care in patients with advanced cancer. J Clin Oncol. 2009; 27: 5559-5564.
27. Smith AK, Earle CC, McCarthy EP,. Racial and ethnic differences in end-of-life care in fee-for-service Medicare beneficiaries with advanced cancer. J Am Geriatr Soc. 2009; 57: 153-158.
28. McCarthy EP, Burns RB, Davis RB, Phillips RS,. Barriers to hospice care among older patients dying with lung and colorectal cancer. J Clin Oncol. 2003; 21: 728-735.
29. Fried TR, Van Ness PH, Byers AL, Towle VR, O'Leary JR, Dubin JA,. Changes in preferences for life-sustaining treatment among older persons with advanced illness. J Gen Intern Med. 2007; 22: 495-501.
30. Catalano P, Ayanian JZ, Weeks JC, et al., Representativeness of participants in the Cancer Care Outcomes Research and Surveillance consortium relative to the Surveillance, Epidemiology, and End Results Program. Med Care. 2013; 51: e9-e15.